Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

2024 is the year to own Salesforce, says Wolfe Research

Published 12/18/2023, 07:51 AM
Updated 12/18/2023, 07:53 AM
© Reuters.  2024 is the year to own Salesforce (CRM), says Wolfe Research

Wolfe Research upgraded Salesforce (NYSE:CRM) stock to Outperform from Peer Perform with a $315 price target on Monday. The firm believes that 2024 is the year to own Salesforce, citing several reasons for its optimism.

"Last year we downgraded CRM to PP after F3Q23 earnings given the combination of growth deceleration, management disruption, lack of commitment to margin leverage and incremental execution risk from M&A mis-adventures," analysts wrote in the note. "Fast forward 365 days (and a few good activists), and we think CY24 is the year to own this value growth stock."

The analysts' core thesis is that Salesforce's growth has bottomed and should stay in the double digits for the foreseeable future, driven by pricing increases, product cycles, and artificial intelligence (AI). They also believe that Salesforce is committed to margin leverage and that its leadership team is stable.

Despite mixed field checks, the company's third quarter showed that Salesforce is back to executing, with Cloud Commerce (CC) cRPO growth accelerating to 13% and non-GAAP operating margins expanding from 23% to 31%.

Wolfe Research is also bullish on Salesforce's prospects from its GenAI-driven product cycle, which includes Data Cloud and Einstein GPT. The investment firm said its checks suggest Data Cloud is in nearly all conversations and that it was part of six of the top ten deals in the most recent quarter.

Additionally, Salesforce added 1,000 new Data Cloud customers and 17% of the Fortune 100 are now Einstein GPT Copilot customers, Wolfe Research noted.

Analysts also see double-digit upside to consensus free cash flow (FCF) estimates over the next two years. They also stated that "30% operating margins are cool, but getting to 40% over the next few years would be iconic."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The company's shift to profitability has caused shares to re-rate, and we continue to see upside to FCF and EPS targets all while CRM is entering a product cycle around GenAI," said Wolfe Research. "We believe adoption of new products and sustained pricing power can drive double-digit top-line growth in 2024, all while margins continue to inflect as the risk or large scale dilutive M&A appears to be dissipating."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.